Related Experiment Video
Updated: Aug 9, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Treatment of Rocky Mountain spotted fever in children
1McWhorter School of Pharmacy, Samford University, Birmingham, AL 35229, USA.
Insights
Doxycycline is the preferred treatment for Rocky Mountain spotted fever (RMSF) in children under 9. It offers proven effectiveness and a better safety profile compared to other antibiotics for pediatric RMSF cases.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Therapy
- Rickettsial Infections
Background:
- Rocky Mountain spotted fever (RMSF) is a severe, life-threatening illness requiring immediate diagnosis and treatment.
- Limited safe and effective antimicrobial options exist for treating RMSF in young children.
- The safety and efficacy of fluoroquinolones and oral chloramphenicol are not established in pediatric populations.
Purpose of the Study:
- To evaluate the optimal antimicrobial agent for treating RMSF in children younger than 9 years of age.
- To compare the safety and efficacy of doxycycline with other potential treatments for pediatric RMSF.
Main Methods:
- Review of existing literature and clinical data on RMSF treatment in pediatric patients.
- Analysis of safety profiles, efficacy data, and dosing schedules of various antimicrobial agents.
- Assessment of risks associated with specific drugs, including dental staining and adverse effects.
Main Results:
- Doxycycline is identified as the most favorable agent for treating RMSF in children under 9.
- Doxycycline demonstrates documented effectiveness and a broader safety margin in this age group.
- The risk of drug-related adverse effects and dental staining is reduced with doxycycline, even for recurrent RMSF infections.
Conclusions:
- Doxycycline is the recommended first-line treatment for RMSF in children under 9 years old.
- The established safety and efficacy of doxycycline support its use in pediatric RMSF cases.
- Up to five courses of doxycycline can be administered for RMSF reinfection with minimal risk of dental staining.
Abstract:
RMSF is a potentially life-threatening disease that requires prompt diagnosis and empiric initiation of an appropriate antimicrobial agent. For the clinician treating young children with RMSF, there are few options. The safety and efficacy of fluoroquinolones and orally administered parenteral chloramphenicol have not been established in the pediatric population. Therefore, widespread and casual use of these agents is not recommended. Doxycycline is the most favorable agent for the treatment of RMSF in children younger than 9 years of age because of its documented effectiveness, broader margin of safety, reduced risk of drug-related adverse effects in young children, and convenient dosing schedule. For patients with RMSF reinfection, up to five courses of doxycycline may be administered with minimal risk of dental staining.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Acute Pyelonephritis II: Diagnostic Studies and Management
Rocky Mountain Spotted Fever
Antiprotozoal Agents

